Cui S. METTL3 ‐mediated m6A modification of lnc RNA RHPN1‐AS1 enhances cisplatin resistance in ovarian cancer by activating PI3K / AKT pathway. Clinical Laboratory Analysis 2022. [DOI: 10.1002/jcla.24761][Reference Citation Analysis]
2
Shao T, Jiang X, Bao G, Li C, Guo C, Hashmi AA. Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies. Disease Markers 2022;2022:1-13. [DOI: 10.1155/2022/7571066][Reference Citation Analysis]